Fortis Healthcare Ltd Faces Bearish Momentum Amid Technical Downturn

Technical Trend Shift and Price Movement

Fortis Healthcare’s share price closed at ₹768.20 on 1 Oct 2026, down sharply by 6.20% from the previous close of ₹819.00. The intraday range was wide, touching a low of ₹757.40 and a high of ₹822.10, indicating heightened volatility. This price action comes against the backdrop of a 52-week high of ₹1,105.00 and a low of ₹757.40, placing the current price near the lower end of its annual range.

The technical trend has deteriorated from mildly bearish to outright bearish, signalling increased selling pressure. This shift is corroborated by multiple technical indicators across different timeframes, suggesting a sustained downtrend rather than a short-term correction.

MACD and Momentum Indicators

The Moving Average Convergence Divergence (MACD) indicator remains bearish on the weekly chart and mildly bearish on the monthly chart. The weekly MACD histogram continues to show negative momentum, with the MACD line below the signal line, confirming the dominance of sellers. The monthly MACD, while only mildly bearish, indicates that longer-term momentum is weakening but not yet decisively negative.

Complementing this, the Know Sure Thing (KST) oscillator also signals bearishness on the weekly timeframe and mild bearishness monthly, reinforcing the view that momentum is shifting unfavourably for Fortis Healthcare.

Relative Strength Index and Bollinger Bands

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in a neutral zone. This suggests that while the stock is not yet oversold, it lacks upward momentum to push prices higher. Meanwhile, Bollinger Bands on weekly and monthly charts are bearish, with the price trending near the lower band, indicating increased volatility and a potential continuation of the downward trend.

Moving Averages and Volume Analysis

Daily moving averages have turned bearish, with the stock trading below its short-term and medium-term averages. This technical configuration typically signals a negative price outlook in the near term. On-balance volume (OBV) readings are mildly bearish on both weekly and monthly charts, suggesting that volume trends are not supporting any price recovery and that selling pressure is gradually increasing.

Dow Theory and Broader Market Context

According to Dow Theory assessments, the weekly and monthly trends are mildly bearish, indicating that the broader market sentiment for Fortis Healthcare remains cautious. This aligns with the stock’s underperformance relative to the benchmark Sensex over recent periods.

Comparative Returns and Market Capitalisation

Fortis Healthcare, classified as a mid-cap hospital sector stock, has delivered mixed returns compared to the Sensex. Over the past week, the stock declined by 13.78%, significantly underperforming the Sensex’s 3.14% fall. The one-month return shows a similar pattern, with Fortis down 17.40% versus the Sensex’s 6.19% decline.

Year-to-date, Fortis Healthcare’s return stands at -13.06%, slightly outperforming the Sensex’s -14.95%. However, over the one-year horizon, the stock has underperformed considerably, falling 20.82% compared to the Sensex’s 9.70% loss. Despite recent weakness, Fortis has delivered strong long-term gains, with three-, five-, and ten-year returns of 125.97%, 191.59%, and 361.10% respectively, far outpacing the Sensex’s corresponding returns of 10.10%, 22.59%, and 160.10%.

Mojo Score and Rating Revision

MarketsMOJO has downgraded Fortis Healthcare’s Mojo Grade from Hold to Sell as of 15 Sep 2026, reflecting the deteriorating technical and fundamental outlook. The current Mojo Score stands at 38.0, signalling weak momentum and caution for investors. This downgrade is consistent with the bearish signals from technical indicators and the stock’s recent price underperformance.

The downgrade also factors in the hospital sector’s competitive pressures and Fortis’s challenges in sustaining growth amid rising costs and regulatory scrutiny. Investors should weigh these risks carefully against the company’s long-term growth potential.

Technical Outlook and Investor Implications

Given the confluence of bearish signals from MACD, Bollinger Bands, moving averages, and volume indicators, Fortis Healthcare’s technical outlook remains negative in the short to medium term. The absence of a clear RSI signal suggests that the stock is not yet oversold, implying further downside risk before a potential recovery.

Investors should monitor key support levels near the 52-week low of ₹757.40, which has been tested intraday recently. A sustained break below this level could trigger further declines. Conversely, a rebound above the daily moving averages and a positive shift in MACD or KST indicators would be required to signal a reversal in momentum.

Long-Term Performance Context

Despite recent setbacks, Fortis Healthcare’s long-term performance remains impressive. Over the past decade, the stock has delivered a cumulative return of 361.10%, more than double the Sensex’s 160.10% gain. This reflects the company’s ability to capitalise on India’s growing healthcare demand and expand its hospital network.

However, the current technical deterioration and rating downgrade suggest that investors should exercise caution and consider the timing of entry or exit carefully. The mid-cap status of Fortis Healthcare also implies higher volatility compared to large-cap peers, necessitating a disciplined approach to risk management.

Conclusion

Fortis Healthcare Ltd is currently navigating a challenging phase marked by bearish technical momentum and a downgrade in its Mojo Grade to Sell. The convergence of negative signals from MACD, Bollinger Bands, moving averages, and volume indicators points to continued downward pressure on the stock price in the near term. While the company’s long-term fundamentals and historical returns remain strong, investors should remain vigilant and consider alternative opportunities until a clear technical recovery emerges.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today